Rigel Pharmaceuticals (RIGL) revenue and earnings history
Rigel Pharmaceuticals reported revenue of $294M for fiscal 2025 (year ended Dec 31, 2025), +64.1% on the year before, and net income of $367M.
Over 9 years, from fiscal 2016 to fiscal 2025, revenue grew at a compound rate of +34.5% a year.
Revenue and net income, 17 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $294M+64.1% | $125M | $367M | $75.7M | — | — | $12.7M | — | — | $40.6M | $52.5M | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Rigel Pharmaceuticals (RIGL) on OQRO.
Common questions
What was Rigel Pharmaceuticals's revenue in fiscal 2025?
$294M for the year ended Dec 31, 2025, as reported in its 10-K filed Mar 3, 2026. That is +64.1% on fiscal 2024 ($179M).
How fast has Rigel Pharmaceuticals's revenue grown?
From $20.4M in fiscal 2016 to $294M in fiscal 2025: a compound annual growth rate of +34.5% over 9 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Rigel Pharmaceuticals been profitable?
It reported a net loss in 5 of the years shown (2019, 2020, 2021, 2022, 2023). The highest net income was $367M in fiscal 2025.
Where these figures come from
The SEC’s companyfacts data: every figure Rigel Pharmaceuticals tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
